Trial
NCT04472897
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Tuberculosis
Intervention
GSK2556286
Why stopped
A decision to stop the study was made by the site and GSK project team based on pre-defined stopping criteria in the protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-11